Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.71
-0.01 (-0.05%)
At close: Nov 26, 2025, 4:00 PM EST
21.50
-0.21 (-0.97%)
After-hours: Nov 26, 2025, 5:13 PM EST
Innoviva Market Cap
Innoviva has a market cap or net worth of $1.62 billion as of November 26, 2025. Its market cap has increased by 28.88% in one year.
Market Cap
1.62B
Enterprise Value
1.41B
1-Year Change
28.88%
Ranking
Category
Stock Price
$21.71
Market Cap Chart
Since October 5, 2004, Innoviva's market cap has increased from $743.40M to $1.62B, an increase of 118.35%. That is a compound annual growth rate of 3.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.62B | 49.45% |
| Dec 31, 2024 | 1.09B | 5.65% |
| Dec 29, 2023 | 1.03B | 11.18% |
| Dec 30, 2022 | 924.60M | -22.87% |
| Dec 31, 2021 | 1.20B | -4.58% |
| Dec 31, 2020 | 1.26B | -12.40% |
| Dec 31, 2019 | 1.43B | -18.66% |
| Dec 31, 2018 | 1.76B | 15.03% |
| Dec 29, 2017 | 1.53B | 31.74% |
| Dec 30, 2016 | 1.16B | -6.00% |
| Dec 31, 2015 | 1.24B | -24.18% |
| Dec 31, 2014 | 1.63B | -48.60% |
| Dec 31, 2013 | 3.18B | 81.10% |
| Dec 31, 2012 | 1.75B | 15.68% |
| Dec 30, 2011 | 1.52B | 16.20% |
| Dec 31, 2010 | 1.30B | 94.91% |
| Dec 31, 2009 | 669.40M | 8.40% |
| Dec 31, 2008 | 617.50M | -35.48% |
| Dec 31, 2007 | 957.00M | -35.96% |
| Dec 29, 2006 | 1.49B | 30.34% |
| Dec 30, 2005 | 1.15B | 49.85% |
| Dec 31, 2004 | 765.10M | 2.92% |
| Oct 5, 2004 | 743.40M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |